98%
921
2 minutes
20
Background: Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. A blanking period (BP) of 3 months is used in clinical trials and practice. However, the optimal BP duration after PVI remains undefined.
Objective: The aim of this study was to objectively define, using continuous monitoring by an implantable loop recorder, the optimal BP duration after cryoballoon PVI.
Methods: We enrolled consecutive patients who had cryoballoon PVI and an implantable loop recorder. We determined the time of the last confirmed episode of AF within the blanking period. This was then correlated with AF recurrence in the first year after ablation.
Results: There were 210 patients (66 ± 9 years; 138 [66%] male; 116 [55%] paroxysmal AF; CHADS-VASc score, 2.5 ± 1.6). We defined 4 distinct groups based on the last AF episode within the BP: no AF days 0-90 (n = 96 [46%]) and last AF 0-30 days (n = 46 [22%]), 31-60 days (n = 18 [9%]), and 61-90 days (n = 50 [24%]). After the 3-month BP, 101 (48%) patients had AF recurrence at 160 ± 86 days. Compared with patients with no AF in the BP, those with recurrent AF and AF burden >0% 30 days after ablation had a significantly greater AF recurrence during long-term follow-up (P = .001).
Conclusion: Our data show that the approximately one-third of patients in whom AF occurs and who have a burden of >0% after the first month that follows PVI are at significantly higher risk of long-term recurrent AF. We therefore suggest that the blanking period be limited to a month after cryoballoon PVI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hrthm.2024.02.014 | DOI Listing |
Heart Rhythm O2
August 2025
Department of Electrophysiology, TUM University Hospital German Heart Center, Munich, Germany.
Background: Data on atrial fibrillation (AF) ablation using high-power short-duration (HPSD) ablation in patients over 80 years are lacking.
Objective: This study aimed to compare the safety and efficacy of paroxysmal and persistent AF ablation using an HPSD (60-90 W/4-8 sec) vs conventional ablation (30-40 W/30 sec) in a propensity score-matched cohort of patients older than 80 years.
Methods: Overall, 232 consecutive patients aged over 80 years undergoing AF ablation were included.
J Cardiovasc Electrophysiol
September 2025
Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Center for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Aims: The impact of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on atrial fibrillation (AF) recurrence after catheter ablation is still inconclusive. Besides, their efficacy on AF recurrence stratified by metabolic syndrome (MetS) status remains unknown.
Methods: Patients with AF undergoing initial catheter ablation between January 2017 and December 2023 from the China-AF Registry were included.
Europace
September 2025
Baptist Health, Louisville, KY, United States.
JACC Clin Electrophysiol
August 2025
Department of Cardiology and. Electronic address:
Background: The performance of cryoballoon (CB) ablation compared with radiofrequency (RF) ablation has been demonstrated in patients with paroxysmal atrial fibrillation (AF). However, the role of CB ablation in patients with persistent AF has not been well established. Furthermore, the efficacy of additional posterior wall isolation following CB pulmonary vein (PV) isolation remains controversial.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.
Importance: Atrial fibrillation (AF) ablation aims to eliminate all AF triggers. Non-pulmonary vein (PV) triggers are observed in up to 10% of patients referred for a first AF ablation procedure. However, there are limited data on sex-specific differences in non-PV triggers.
View Article and Find Full Text PDF